Sodium Hydroxide → HCID 13454594, compound
Reaction equation
Cl.C([O:4][C:5]([C@@H:7]([NH:16][C@@H:17]1[C:23](=[O:24])[N:22]([CH2:25][C:26]([OH:28])=[O:27])[C:21]2[CH:29]=[CH:30][CH:31]=[CH:32][C:20]=2[S:19][CH2:18]1)[CH2:8][CH2:9][CH:10]1[CH2:15][CH2:14][CH2:13][CH2:12][CH2:11]1)=[O:6])C.[OH-].[Na+]>CO>[C:5]([C@@H:7]([NH:16][C@@H:17]1[C:23](=[O:24])[N:22]([CH2:25][C:26]([OH:28])=[O:27])[C:21]2[CH:29]=[CH:30][CH:31]=[CH:32][C:20]=2[S:19][CH2:18]1)[CH2:8][CH2:9][CH:10]1[CH2:15][CH2:14][CH2:13][CH2:12][CH2:11]1)([OH:6])=[O:4]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
In 2 ml of methanol are dissolved 0.1 g of 3(R)-[1(S)-ethoxycarbonyl-3-cyclohexylpropyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid hydrochloride and 1.5 ml of 1N aqueous sodium hydroxide. The solution is allowed to stand at room temperature for 2 hours, concentrated to about 1 ml at a temperature of not higher than 40° C. under reduced pressure, and acidified slightly with 1N hydrochloric acid to give 0.067 g of 3(R)-[1(S)-carboxy-3-cyclohexylpropyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid as colorless prisms, m.p. 207°-210° C.
Workup
- concentrationconcentrated to about 1 ml at a temperature of not higher than 40° C. under reduced pressure
Sources & evidence
- ORD record
- ord-c979a1cac4ed4d05aaf2fcc2c123ea12
- Source dataset
- uspto-grants-1986_01
- Patent number
- US04564612
Reaction notes
Loading…